Pharmaceutical erythropoietin use in patients with cancer: is it time to abandon ship or just drop anchor?
- PMID: 17976350
- DOI: 10.4065/82.11.1316
Pharmaceutical erythropoietin use in patients with cancer: is it time to abandon ship or just drop anchor?
Comment on
-
Use of erythropoiesis-stimulating agents in patients with anemia of chronic kidney disease: overcoming the pharmacological and pharmacoeconomic limitations of existing therapies.Mayo Clin Proc. 2007 Nov;82(11):1371-80. doi: 10.4065/82.11.1371. Mayo Clin Proc. 2007. PMID: 17976358 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
